Persistence of Granuloma or granulomatous Inflammation after Six Months of CAT-1 Anti Tuberculosis Therapy in Tubercular Lymphadenitis Patients
DOI:
https://doi.org/10.3329/bjms.v22i1.63081Keywords:
Tubercular Lymphadenitis; persistent lymph node; post anti-TB treatmentAbstract
Background: Tuberculous Lymphadenitis is the most common form of extra-pulmonary tuberculosis. Paradoxical enlargement and new lymph nodes appearance are observed after completion of anti-tuberculous therapy.
Objective: The objective of the study was to assess whether granuloma can persist in persisted or paradoxically enlarged lymph node after anti-TB treatment in tubercular lymphadenitis patient.
Method: An observational cross sectional study was conducted in the Department of Internal Medicine, Bangabandhu Sheikh Mujib Medical University from March 2014 to February 2016 among patients of TB-lymphadenitis who had persistent or enlargement of previous or developed new lymph node after anti-TB therapy. History was taken; previous records were analyzed to ascertain the diagnostic basis of tuberculosis. History and physical examination were done for present status. Cytological or histopathological analysis was done at Department of Pathology, BSMMU.
Result: Most of the patients were in the 21-30 years age group (Mean 25.53±7.93). Majority of them were female. Most of the respondents were student. More than half of the patients came from lower socioeconomic status. About 89% had typical symptoms of tuberculosis like fever, weight loss and loss of appetite during initial diagnosis and about one third had typical symptom of TB like fever weight loss and loss of appetite and one third had no symptoms after treatment. Majority mode of diagnostic tool was FNAC in both initial and after treatment. Majority (88.9 %) cases granuloma persisted after treatment.
Conclusion: In spite of anti TB treatment with good compliance granuloma or granulomatous inflammation persisted in majority patients of persisted lymph nodes.
Bangladesh Journal of Medical Science Vol. 22 No. 01 January’23 Page : 216-221
Downloads
82
81
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Mohammad Farhad, Shohael Mahmud Arafat, Mohammad Kamruzzaman Mazumder, Md Rashadul Kabir, Shah Mohammad Mohaimenul Haq, Muhammad Jamal Uddin, Md Nazim Al Azad, Md Saiful Islam Patwary, Mahmuda Khatoon, ABM Abdullah
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.
